Skip to main content
Home/Guides/Best Robotics Stocks 2026
📈 Investor GuideUpdated June 2026

Best Robotics Stocks to Watch in 2026 — Investor Guide

Robotics is entering its "iPhone moment." Industrial automation, humanoid robots, and surgical systems are converging into a multi-trillion-dollar market. Here are the 12 stocks and ETFs covering this transformation.

⚠️ This is for informational purposes only. Not financial advice. Always do your own research before investing.

5 Robotics Investment Themes for 2026

🤖
Humanoid Robot Wave
Very High Risk2025-2028

Tesla Optimus, Figure AI, Agility Robotics, 1X, and Apptronik all plan commercial deployments in 2026-2027. The TAM is enormous if they succeed. Most are private — watch for IPOs.

Key stocks: TSLA, NVDA (picks & shovels)
🏭
EV Factory Automation
Medium Risk2024-2028

EV gigafactory buildouts require massive robot investment — welding, battery assembly, paint, logistics. FANUC and ABB are direct beneficiaries. Multi-year capex cycle.

Key stocks: FANUF, ABB, YASK
📦
Warehouse & Logistics AMRs
Medium-High Risk2024-2026

E-commerce growth and labor shortages drive warehouse robot demand. Symbotic, KION/Dematic, Honeywell Intelligrated, and AutoStore are key players.

Key stocks: SYM, KIGRY, HON
🏥
Surgical Robotics
Medium RiskNow

The most proven robotics market: real revenue, real margins, defensible IP. ISRG dominates, but competitors are gaining. New procedure categories (soft tissue, spine) expanding TAM.

Key stocks: ISRG, MDT (Hugo)
🛡️
Defense Drones & Autonomy
Medium Risk2024-2027

Military drone demand surged post-Ukraine. AeroVironment, Shield AI, and Kratos Defense are pure-play defense robotics plays. DARPA autonomy programs driving R&D spending.

Key stocks: AVAV, KTOS

12 Robotics Stocks & ETFs to Watch

Ranked loosely by robotics revenue purity — pure-plays first, diversified last.

1
ISRG
Intuitive Surgical
Surgical RoboticsPure Play

The dominant surgical robot platform (da Vinci) with a 70%+ global market share. A 'razor/blade' model where installed base of 8,500+ systems drives high-margin instrument revenue (~60% of total). Ion bronchoscopy extends into new procedures.

Exposure: ~100% surgical robotics revenue
Catalysts
  • da Vinci 5 system ramp (significantly more sensors, force feedback)
  • Ion procedure volume expansion (lung nodule biopsy)
  • International market penetration — Japan, China regulatory approvals
Key Risks
  • Competition from Medtronic Hugo, CMR Versius gaining traction
  • High valuation (P/E typically 60-80x) leaves no margin for error
  • Hospital capital budget constraints slow new system placements
2
FANUC
FANUC Corp (FANUF)
Industrial RoboticsPure Play

World's largest industrial robot manufacturer by installed base. Yellow robots are ubiquitous in EV battery and electronics manufacturing. Strong service/parts aftermarket revenue stream.

Exposure: ~90%+ industrial automation revenue
Catalysts
  • EV gigafactory buildouts driving record FANUC robot orders
  • AI-enhanced CNC systems (iHMI) gaining traction in precision machining
  • China manufacturing reshoring alternatives in Vietnam/Mexico
Key Risks
  • China revenue exposure (~30%) — geopolitical and demand risk
  • Automotive cycle downturn would reduce robot orders significantly
  • Currency risk — Japanese yen denominated
3
AGIO
Agility Robotics (Private)
Humanoid RobotsPure Play

Building Digit, the first commercially deployed humanoid in Amazon warehouses. Partnerships with GXO and other 3PLs expanding. IPO widely anticipated in 2026-2027.

Exposure: Pre-IPO — accessible via crossover funds only
Catalysts
  • Amazon deployment scale-up (target: 750+ units by end of 2026)
  • GXO Logistics partnership for logistics humanoid deployment
  • IPO event — private investors estimate $3-5B valuation
Key Risks
  • Currently private — no direct public stock access
  • Competition from Figure, 1X, Boston Dynamics, Tesla Optimus
  • Deployment reliability unproven at scale
4
TSLA
Tesla
Humanoid RobotsMajor Segment

Optimus humanoid could be the most valuable robotics product of the decade if Tesla can produce at automotive scale. Vertically integrated: AI, actuators, batteries, manufacturing. Musk targets 1M units/year by 2030.

Exposure: Optimus ~1-5% of current value; EV + energy are core
Catalysts
  • Optimus Gen 3 deployment in Tesla factories — proof of commercial viability
  • External sales announcement (non-Tesla customers)
  • FSD autonomous driving AI cross-applied to robot navigation
Key Risks
  • Execution risk — Tesla has delayed robotics milestones repeatedly
  • Optimus is a tiny % of current revenue; stock priced for multiple futures
  • Competitive threat from purpose-built humanoid companies
5
IRBT
iRobot
Consumer RoboticsPure Play

Roomba inventor under significant pressure — Amazon acquisition blocked by EU regulators in 2024. Refocusing on core vacuum products and international markets. Deep value play if turnaround succeeds.

Exposure: Consumer robot vacuums only — single product dependency
Catalysts
  • International market share recovery (EU, Japan)
  • New product categories: Roomba Combo with AI object avoidance
  • Potential acquisition interest from Asian consumer electronics players
Key Risks
  • Chinese competitors (Roborock, Dreame, Ecovacs) taking market share aggressively
  • Post-Amazon rejection, balance sheet concerns persist
  • Consumer discretionary headwinds — Roomba is non-essential
6
NVDA
NVIDIA
Robotics AI InfrastructureDiversified

Isaac Sim, Isaac Lab, and the Jetson edge AI platform make NVIDIA the picks-and-shovels play for all of robotics. Every humanoid company (Figure, 1X, Apptronik, Agility) trains on NVIDIA GPUs.

Exposure: Robotics ~3-8% of revenue; AI/data center is core
Catalysts
  • Isaac GR00T foundation model for humanoid robots — licensing revenue
  • Jetson Thor module for next-gen robotics compute
  • GTC robotics announcements driving new revenue streams
Key Risks
  • Robotics is a small % of massive NVIDIA revenue — data center dominates
  • AMD and custom silicon (Google TPU, Amazon Trainium) competing for training
  • Valuation extreme — any growth deceleration hits stock hard
7
HON
Honeywell
Warehouse AutomationDiversified

Industrial conglomerate with a strong warehouse automation division (Intelligrated). Software-defined automation platform and AMR partnerships with Zebra. Stable cash flows, consistent dividend growth.

Exposure: Warehouse automation ~15-20% of revenue
Catalysts
  • E-commerce expansion driving warehouse automation capex
  • Aerospace business demerger unlocking hidden value
  • Connected Enterprise software margins expanding
Key Risks
  • Robotics is one of many divisions — not a pure-play
  • Industrial cycle exposure; slow growth in legacy automation
  • Management focus diluted across aerospace, buildings, energy
8
KION
KION Group (KIGRY)
Warehouse RoboticsMajor Segment

Owner of Dematic (warehouse automation systems) and Still/Linde forklifts. Large installed base in European and US logistics. Benefits from e-commerce growth and labor shortage tailwinds.

Exposure: ~40% Dematic automation revenue; ~60% forklift products
Catalysts
  • Dematic project backlog clearing — revenue recognition acceleration
  • Autonomous mobile robot integration into Dematic systems
  • European manufacturing reshoring driving automation investment
Key Risks
  • High debt from Dematic acquisition weighing on balance sheet
  • Germany economic slowdown reducing industrial capex
  • Competition from Symbotic, Berkshire Grey (Amazon), AutoStore
9
ABB
ABB Ltd
Industrial RoboticsMajor Segment

One of the Big 4 industrial robot makers (alongside FANUC, KUKA, Yaskawa). Strong in electronics and EV manufacturing robots. Robotics & Discrete Automation division is ~30% of revenue.

Exposure: Robotics & Discrete Automation ~30% of ABB total revenue
Catalysts
  • EV manufacturing robot orders in North America and Europe
  • AI-powered robot programming (ABB Wizard) reducing setup time
  • Collaboration robot (cobot) market expansion
Key Risks
  • China market slowdown — ABB has significant China exposure
  • Competitive pressure from Chinese robotics (ESTUN, Siasun)
  • Industrial cycle risk — capex-sensitive revenue
10
BOTZ
Global X Robotics & AI ETF
ETF — DiversifiedDiversified

The most popular robotics-focused ETF. Holds FANUC, NVIDIA, ABB, Intuitive Surgical, Zebra, Keyence, and others. Expense ratio 0.68%. Best for investors wanting broad robotics exposure without stock picking.

Exposure: ~40 holdings; top 10 = ~55% of weight
Catalysts
  • Humanoid robot stock additions as companies go public
  • Weight rebalancing toward higher-growth components
  • Rising AUM driving lower effective trading costs
Key Risks
  • 0.68% expense ratio vs. 0% for individual stock holding
  • Top-heavy: NVDA and ISRG dominate weightings
  • May hold non-robotics revenue stocks diluting pure-play exposure
11
ROBO
ROBO Global Robotics & Automation ETF
ETF — Equal WeightDiversified

Equal-weighted robotics ETF with more granular exposure to smaller robotics companies. ~80 holdings, rebalanced quarterly. Expense ratio 0.95%. Better for capturing mid/small-cap robotics upside.

Exposure: ~80 holdings, equal-weighted, quarterly rebalance
Catalysts
  • Small/mid-cap robotics companies disproportionately benefit from sector growth
  • Equal weighting limits mega-cap concentration risk vs. BOTZ
  • Regular additions of new robotics pure-plays
Key Risks
  • 0.95% expense ratio is high for passive exposure
  • Equal weighting drags returns when mega-caps (NVDA) outperform
  • Some holdings have marginal robotics revenue (not true pure-plays)
12
SYMBOTIC
Symbotic (SYM)
Warehouse AutomationPure Play

AI-powered warehouse automation systems deployed inside Walmart, Target, and large 3PLs. High-speed case picking robots with proprietary AI software. Rapid revenue growth, but unprofitable.

Exposure: ~100% warehouse robotics/AI revenue
Catalysts
  • Walmart deployment expansion — largest single customer driving visibility
  • GreenBox joint venture with SoftBank targeting international markets
  • Software subscription revenue (Symbotic AI) improving margins over time
Key Risks
  • Highly concentrated revenue — Walmart is ~85% of revenue
  • Not yet profitable — cash burn and dilution risk
  • Complex implementation; customer delays push revenue recognition

5 Questions to Ask Before Buying

Q: What % of revenue actually comes from robotics?
For ABB it's ~30%. For FANUC it's ~90%. The same stock price movement means very different robotics exposure. Always check the company's segment breakdown.
Q: Is the company growing robotics revenue YoY?
A robotics company with flat or declining unit sales in a growing market is losing share. Look for order intake (backlog) as a leading indicator.
Q: What's the recurring revenue component?
ISRG gets ~60% from instruments and services (recurring). FANUC gets service revenue from installed base. Recurring revenue = more predictable, higher multiple.
Q: How much China exposure does the company have?
FANUC, ABB, and KUKA all have 25-35% China revenue. Geopolitical tension and Chinese domestic robot competition (ESTUN, Siasun gaining share) are real risks.
Q: Are you buying the technology or the stock?
Even the best robotics technology can make a terrible stock if the valuation is too high. ISRG at 80x P/E has limited margin of safety even if the business is excellent.

ETF vs. Individual Stocks

Choose ETFs (BOTZ / ROBO) if:
  • You want broad sector exposure without stock picking
  • You have < $10,000 to invest in robotics
  • You can't track individual company earnings and news
  • You want automatic rebalancing and diversification
Choose Individual Stocks if:
  • You have a specific thesis on a company or segment
  • You want to avoid ETF expense ratios on large positions
  • You track earnings calls and can evaluate management quality
  • You have time to monitor and rebalance manually
Disclaimer

This is for informational purposes only. Not financial advice. Always do your own research before investing. Stock mentions are for educational analysis only. Market prices, company conditions, and competitive dynamics change rapidly. Verify all information with primary sources before making investment decisions.